Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Heva Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxHeva Health
Shoppers who want a concierge lab-panel-plus-GLP-1 bundle and can confirm their state isn't one of tirzepatide's five exclusions.
Visit Heva HealthThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 60. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Heva Health still earns a C — Shoppers who want a concierge lab-panel-plus-GLP-1 bundle and can confirm their state isn't one of tirzepatide's five exclusions.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Heva Health |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 60/100 |
| Semaglutide / mo | $99/mo | $150/mo (starting dose, compounded) |
| Tirzepatide / mo | $149/mo | $339/mo (compounded) |
| Semaglutide / yr (modeled) | $1,188 | $1,800 |
| Tirzepatide / yr (modeled) | $1,788 | $4,068 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #249 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Heva Health
60/100Where the value is
- Tirzepatide pricing is broken out into a clear, labeled ladder ($339/mo month-to-month down to $299/mo on a 6-month plan) rather than a single vague 'starting at' figure
- Explicitly discloses a real state-level restriction for tirzepatide (unavailable in Alaska, Arkansas, Indiana, Minnesota, South Carolina) instead of a vague coverage claim
- Named, credentialed care team (Dr. Caroline Tade NMD, Kasey Horrell PA-C, Dr. Daniel Hall DNP/NP-C, Kelly Moore FNP)
The tradeoffs
- The $149.99/month 'Weight Loss Program' figure is never explicitly confirmed as the semaglutide-specific price on the pages checked — it may be a generic teaser rather than a labeled per-drug rate
- Tirzepatide's '3-Month Program' is listed at the identical $339/month as the month-to-month rate despite being advertised as '15% savings vs month-to-month' — a page inconsistency worth flagging before treating either figure as final
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.